BACKGROUND: Drug-controlled release preparation by drugs or other active substances combined with carriers, has been an important development trend in field of pharmacy. However different characteristics of controlled release drug carrier materials leas to different drug release behaviors, so recent researches focus on a new type of drug carrier material to obtain the satisfactory drug release. OBJECTIVE: To introduce some drug carrier materials, and analyze those materials' characteristics and their application on drug controlled-release. RETRIEVAL STRATEGY: A computer-based search was undertaken on China Journal Full-text Database from January 1998 to June 2007, with the Keywords of "polymeric hydrogel, polylactic acid, chitosan, silk fibroin, drug controlled-release, drug carrier" and language was limited to Chinese. Inclusion criteria: ①preparations and characteristics of various drug carrier materials;②drug controlled release of various drug carrier materials. Exclusion criteria: outdated literatures. LITERATURE EVALUATION: Eighty-six related articles were screened out, and 28 of them met the criteria, including 10 were reviews and others were clinical or basic experiments. DATA SYNTHESIS: ① At present, the materials applied for drug carrier include polymeric hydrogel, polylactic acid/poly(lactic-co-glycolic acid), chitosan and their derivates, silk fibroin and so on.②Intellectual polymeric hydrogel can respond swelling and contraction for the stimulation of temperature, acidity, pressure and light, etc. And the specific environment sensitiveness enlarges its application in drug delivery system.③Polylactic acid and poly(lactic-co-glycolic acid), as a kind of biodegradable polymer materials, represent biocompatibility, biodegradability and non-toxic degradation products. As for controlled release drug carrier material, it can influence drug release by modulating degradation of polylactic acid, so as to increase drug efficacy.④Chitosan is satisfactory in adsorbability, film forming ability and permeability. Water-soluble chitosan with low relative molecular mass is prone to degrade and difficult to accumulate, so chitosan nanoparticles or chitosan microspheres as carriers for drug delivery system have been the hot topic of recent researches.⑤Native polymer material silk fibroin is non-toxic and non-stimulative, shows good physical, chemical and biological characteristics, as well as satisfactory histocompatibility. The pH value responsibility and zymohydrolysis are also observed when loading and releasing drugs. Chemical modification and addition of other compounds will increase the characteristics and the drug-controlled release of silk fibroin. CONCLUSION: Various drug carrier materials show good biocompatibility, biodegradability, physicochemical and biological stability, extremely low toxicity, and high drug loading property. But the material's performance should be synthesized and modified in practical application to satisfy various preparations of drug-controlled release by specific performance and structure.

Polypeptide and protein microspheres can elevate drug availability, but drug devitalization and drug fast release can result in side effects during microsphere preparation. Fast release in the body is a burning question facting investigators who studying microsphere controlled release system. Relative molecular mass, concentration, structure and drug content of the polyme can greatly affect drug fast release. Fast release can be controlled by structural modification, using additives, controlling particl diameter of microspheres and decreasing drug content.

Calcium phosphate ceramics, such as tricalcium phosphate (TCP) and hydroxyapatite (HA) are commonly used as bone substitutes. These materials have different physical and chemical properties and, therefore, display different interactions with the host tissue. Factors such as porosity,osteoconductivity,and biocompatibility seem to become increasingly important in the development of new artificial bone replacement materials. This article focuses on the relationship between the physical and chemical properties of calcium phosphate ceramics and the host tissue.

Objective: To study the impact of basic medical insurance on household consumption. Methods: According to the panel data of the east, central and west regions from 2002 to 2011, time and entity fixed effect model (Two-way FE) is established to test the relationship between the basic medical insurance and household consumption. Results: The basic medical insurance has significant positive effects on consumption, the consumption increased 10%, 16% and 19% in regions of East, Middle and West, respectively. Conclusion: The construction and improvement of the social medical insurance system improve the growth of the consumption, and the government should enhance the security, and consider the regional differences at the same time.

Guidelines as Topic ; Humans ; Infant, Low Birth Weight ; Infant, Newborn ; Infant, Premature ; Nutritional Physiological Phenomena

Breast Feeding ; Enteral Nutrition ; Epigenesis, Genetic ; Humans ; Infant ; Infant Formula ; Infant Nutritional Physiological Phenomena ; Infant, Low Birth Weight ; growth & development ; Infant, Newborn ; Infant, Premature ; growth & development ; Infant, Premature, Diseases ; prevention & control ; Nutrition Assessment ; Nutritional Status

Objective To compare the efficacy and safety of candesartan cilexetil and enalapril in the treatment of senile hypertension.Methods 100 patients with hypertension were randomly divided into the treatment group and control group according to digital table method.The treatment group were received candesartan cilexetil 4 ～ 8mg once daily for 8 weeks,and control group were received enalapril 10 ～ 20mg once daily for 8 weeks,and the efficacy and adverse reactions were watched.Results The SBP and DBP were (134.42 ± 6.39) mmHg and (82.00 ± 5.05) mmHg for candesartan cilexetil and (137.70 ± 5.27) mmHg and (81.76 ± 5.03) mmHg for enalapril after 8 weeks.A significant reduction of blood pressure was achieved in both groups than before treatment (tcan =35.85,30.88;tena =37.92,31.67,all P ＜ 0.01).After treatment pulse pressure was (56.06 ± 4.91)mmHg for candesartan cilexetil and (60.04 ± 4.40) mmHg for enalapril.Compared with before treatment,pulse pressure was significantly reduced in the treatment group (t =16.93,P ＜ 0.01) and was no significant difference in control group (t =6.34,P ＞ 0.05).The incidence of adverse reactions of patients with treatment group was obviously lower than that of the control group.Conclusion Candesartan cilexetil is effective and safe in senile hypertension patients,and it could be used as a first-line treatment.

Some human leucocyte antigens(HLA),espeually class Ⅱ genotypes such as HLA DQ/DR are closely linked to type 1A diabetes mellitus(T1ADM).But the genetic susceptibility of HLA DR/DQ are different between Caucasian and Asian populations.The aspartic acid at position 57 of DQ? can not confer resistance to T1ADM in Asians.DQ2 and DQ8 are the well-known susceptible genotypes in Caucasians while DQ4 and DQ9 are in Asians.An unexpected high risk of T1ADM is observed for the linkage disequilibrium between DRB1*0301/ DRB1*0401 and DQ2/DQ8 in both the populations.The DQB1*0302,DQA1*0501,DRB1*0401,*0402,*0407 are associated with T1ADM in Caucasians,but it is not the case in Asians.In contrast,DQB1*0401 shows a positive association to T1ADM in Asians,has a protective effect against T1ADM in Caucasians.Additionally DRB1*09 could be another susceptible gene in Asians.

Objective To observe the changes of plasma lipoprotein concentrations after an oral glucose tolerance test and research their relation to insulin resistance in Type 2 diabetic patients.Methods The age,duration of diabetes,sex,waist circumference,hip circumference,waist-hip ratio,height,body weight,body mass index ( BMI ),systolic blood pressure,diastolic blood pressure,fasting plasma glucose,HbAl C,fasting insulin,and fasting and 60-,120-,180-minute post-load plasma glucose,plasma insulin,triglycerides ( TG),high-density lipoprotein cholesterol (HDL-C),low-density lipoprotein cholesterol(LDL-C) and total cholesterol(TC) after a 75-g oral glucose tolerance test were measured in 26 Type 2 diabetic patients.Comparison of plasma fasting lipoprotein concentrations and postload lipoprotein concentrations was made,and the relation between fasting and post-load lipoprotein concentrations and Homa-IR was researched.Stepwise multiple regression analysis was applied to investigate the areas under the lipoproteins' curves over 180 minutes.Results The declination of post-load lipoprotein concentrations after the 75-g glucose tolerance test was statistically significant( all P ＜0.01 ).Plasma TG concentration both in fasting and post-load state was positively related to Homa-IR( all P ＜ 0.05 ),and plasma HDL-C concentration in fasting and post-load state was negatively related to Homa-IR( all P ＜ 0.05 ).However,the correlation between both fasting and post-load state LDL-C and TC concentration and Homa-IR had no statistical significance.Moreover,stepwise multiple regression analysis revealed Homa-IR was the independent factor capable of modulating the area of HDL-C curve over 180 minutes after the 75-g glucose tolernce test ( P ＜ 0.05 ).Conclusion There was a significant declination of plasma lipoproteins after a 75-g glucose tolerance test,and plasma fasting and post-load TG and HDL-C concentrations were related to insulin resistance.Insulin resistance should play a significant role in the post-load HDL-C concentration after 75-goral glucose tolerance test.

Ovarian cancer is sex hormone-Dependent.Gonadotropin releasing hormone (GnRH) analogues inhibit ovarian cancer not only through the hypothalamus-pituitary-gonadal axis, but also through directly inhibiting the proliferation and inducing the apoptosis via GnRH receptors on the ovarian carcinoma cells.In addition, GnRH analogues target GnRH receptors on the cancer cells and can serve as a carrier for cytotoxic agents, improving the efficiency of cytotoxic agents and lowering the side effect.In a word, treatment with GnRH analogues may be a valuable alternative for advanced and recurrent ovarian cancer.